This award is for projects undertaken in mental health by pre-registration pharmacists.
The award includes attendance at the CMHP annual conference, held each autumn, with all accommodation and reasonable travel costs included, and two years’ CMHP membership. The award will be made to a winner and runner up.
This is a long-standing award, having been first launched in 2002.
The call for applications opens on 24 April with a closing date of 30 June 2018. The process for submissions is outlined below.
To be eligible for this award, your project must have been undertaken during your pre-registration training: this may either be as part of an undergraduate sandwich course or as part of postgraduate training. The project could be undertaken in any sector of pharmacy, including community, hospital, academia and industry.
Your project must be wholly or mainly about a subject related to the practice of mental health pharmacy. It is anticipated that most projects undertaken by pre-registration pharmacists will be as part of an audit cycle, a literature search and evaluation as part of service development or a service evaluation, although applications need not be limited to such projects.
The work must have been undertaken wholly by you, the applicant; although the project may have been supervised.
To apply, you must have undertaken their pre-registration training in the year leading up to the call for applications.
You must be willing to present your project as a poster at our Annual international conference, and we expect to share winning and runner-up abstracts with the wider membership.
Process of application
Please submit a brief project report describing your work:
- The first page of the report should include the title and author(s) details.
- All subsequent pages must repeat the title as a header.
- All subsequent pages must not mention the author’s name.
- For the sake of anonymity in the marking process, the title and text should exclude any identifying names or places.
- An abstract should be included; please use the IMRAD format (Introduction, Methods, Results and Discussion) (maximum 350 words).
- The report should be no more than 1,500 words long excluding tables and references. A word count should be included.
- The report must be typed in at least 12 point, double-spaced with standard margins, and have numbered pages. Tables, figures and references (numerical style) should be on separate pages at the end.
- As the report will act as the only means of assessing the project, it should be self-contained and self-explanatory
Please provide a covering letter that states:
- The full title of your project
- Your full name and correspondence address (that should be valid after 1st September)
- Your telephone, mobile telephone number and e-mail address (all valid after 1st September )
- The name and address of the supervisor(s) for the project (if appropriate) and all other co-applicants.
- The address(es) of the establishment(s) where the project was undertaken (where the data was collected)
- The address(es) of your pre-registration training establishment(s)
- The name and address of the applicant's pre-registration tutor(s)
- A statement confirming that you undertook the work yourself without assistance other than that of a supervisor
- A statement acknowledging that you are willing to present your project as a poster at the CMHP Annual Conference.
Submissions must be emailed to email@example.com by 5pm on 30 June 2018.
A panel of judges will consider the applications anonymously.
The decision of the judges is final; no communications will be entered into.
An award will be made to a winner and runner up. The winner and runner-up will be notified in writing by the 1st September. The award will enable attendance at the CMHP Annual Psychiatric Pharmacy Conference, where the award will be made. All accommodation and reasonable travel costs will be funded as part of the bursary, and two years’ CMHP membership will also be provided.
This award is funded by the CMHP.
2017: Clare Geoghegan, Worthing Hospital, Western Sussex Hospitals NHS Foundation Trust: Audit of Documentation of Clozapine in GP records
2016: Shabnam Sobhdam, Central and North West London NHS Foundation Trust: An audit of the number and type of dispensing errors that are identified at the final checking stage in the dispensary at St Charles’ Hospital.
2015: Heather Axford: A clinical audit of the documentation of medicines reconciliation on admission to York-based Mental Health Inpatient Beds
2014: Zahra Javadi: An audit of Rapid Tranquilisation use within Central and North West London (CNWL) NHS Foundation Trust
2013 Kristina Sakenyte: Reported medication errors in MH crisis resolution and home treatment teams
2012: Eleanor Bevan, Heart of England Foundation Trust - An audit on the adherence to the new recommendation for the use of citalopram.
2011: Lorna Hand, Sherwood Forest Hospitals - An audit of clozapine use in assertive outreach teams.
2010: Jacqueline Payne - Do assertive outreach patients with schizophrenia receive adequate cardiovascular risk monitoring as per NICE Guidance?
2009 Joint winners: Helen Frances Wade - The Off-label use of psychotropic’s for unlicensed indications in Adult Inpatients, and Louise Millen - A clinical audit of the use of antipsychotics in the management of BPSD
2007: Mohammed Miah, Newham Centre for Mental Health NHS Trust - An audit on usage of benzodiazepines.